128 related articles for article (PubMed ID: 12089508)
1. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1.
Matthias LJ; Yam PT; Jiang XM; Vandegraaff N; Li P; Poumbourios P; Donoghue N; Hogg PJ
Nat Immunol; 2002 Aug; 3(8):727-32. PubMed ID: 12089508
[TBL] [Abstract][Full Text] [Related]
2. Disulfide bond switches.
Finkel E
Nat Biotechnol; 2002 Sep; 20(9):887. PubMed ID: 12205507
[No Abstract] [Full Text] [Related]
3. Presence of closely spaced protein thiols on the surface of mammalian cells.
Donoghue N; Yam PT; Jiang XM; Hogg PJ
Protein Sci; 2000 Dec; 9(12):2436-45. PubMed ID: 11206065
[TBL] [Abstract][Full Text] [Related]
4. Human CD4 Metastability Is a Function of the Allosteric Disulfide Bond in Domain 2.
Owen GR; Channell JA; Forsyth VT; Haertlein M; Mitchell EP; Capovilla A; Papathanasopoulos M; Cerutti NM
Biochemistry; 2016 Apr; 55(15):2227-37. PubMed ID: 27009680
[TBL] [Abstract][Full Text] [Related]
5. Determination of the DeltapKa between the active site cysteines of thioredoxin and DsbA.
Carvalho AT; Fernandes PA; Ramos MJ
J Comput Chem; 2006 Jun; 27(8):966-75. PubMed ID: 16586531
[TBL] [Abstract][Full Text] [Related]
6. Novel biotinylated phenylarsonous acids as bifunctional reagents for spatially close thiols: studies on reduced antibodies and the agonist binding site of reduced Torpedo nicotinic receptors.
Moaddel R; Sharma A; Huseni T; Jones GS; Hanson RN; Loring RH
Bioconjug Chem; 1999; 10(4):629-37. PubMed ID: 10411461
[TBL] [Abstract][Full Text] [Related]
7. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
[TBL] [Abstract][Full Text] [Related]
8. The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects.
Sahaf B; Heydari K; Herzenberg LA; Herzenberg LA
Arch Biochem Biophys; 2005 Feb; 434(1):26-32. PubMed ID: 15629105
[TBL] [Abstract][Full Text] [Related]
9. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
[TBL] [Abstract][Full Text] [Related]
10. Redox exchange of the disulfides of human two-domain CD4 regulates the conformational dynamics of each domain, providing insight into its mechanisms of control.
Owen GR; Le D; Stoychev S; Cerutti NM; Papathanasopoulos M
Biochem Biophys Res Commun; 2018 Mar; 497(2):811-817. PubMed ID: 29470989
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin (Trx1) regulates CD4 membrane domain localization and is required for efficient CD4-dependent HIV-1 entry.
Moolla N; Killick M; Papathanasopoulos M; Capovilla A
Biochim Biophys Acta; 2016 Sep; 1860(9):1854-63. PubMed ID: 27233453
[TBL] [Abstract][Full Text] [Related]
12. Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry.
Bourgeois R; Mercier J; Paquette-Brooks I; Cohen EA
Retrovirology; 2006 Jun; 3():31. PubMed ID: 16762062
[TBL] [Abstract][Full Text] [Related]
13. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
14. Redox control on the cell surface: implications for HIV-1 entry.
Matthias LJ; Hogg PJ
Antioxid Redox Signal; 2003 Feb; 5(1):133-8. PubMed ID: 12626125
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
16. Protein minimization of the gp120 binding region of human CD4.
Sharma D; Balamurali MM; Chakraborty K; Kumaran S; Jeganathan S; Rashid U; Ingallinella P; Varadarajan R
Biochemistry; 2005 Dec; 44(49):16192-202. PubMed ID: 16331979
[TBL] [Abstract][Full Text] [Related]
17. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1.
Meyuhas R; Noy H; Montefiori DC; Denisova G; Gershoni JM; Gross G
Mol Immunol; 2005 May; 42(9):1099-109. PubMed ID: 15829299
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 infection: is it time to reconsider our concepts?
Krambovitis E; Spandidos DA
Int J Mol Med; 2006 Jul; 18(1):3-8. PubMed ID: 16786149
[TBL] [Abstract][Full Text] [Related]
20. Pyridoxal 5'-phosphate as a novel weapon against autoimmunity and transplant rejection.
Namazi MR
FASEB J; 2003 Dec; 17(15):2184-6. PubMed ID: 14656979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
